66% of patients with symptomatic HCM with outflow tract obstruction improve NYHA class with mevacampten many NYHA I. Game changer for these patients. Fascinating talk from Alison Muir. #mdt25 #freedomfromfailure @BSHeartFailure rate limiting step is lack of echo
THINK AMYLOID! More prevalent than we realise. Look for the red flags. HF nurses are well placed to question red flags and escalate patients for diagnosis and treatment . Geraint Jenkins #mdt25 #freedomfromfailure @BSHNurseForum @WelshHFNF @BSHeartFailure
Genetic screening of inherited cardiomyopathies. Great talk from Julian Omerod. I understand a wee bit more every time ! Kudos to ICC teams #mdt25 #freedomfromfailure @BSHeartFailure
Aaron Wong teaching us the difference in MRAs , which to use when and use in HFpEF. Geographic variation raises questions from topcat ⬆️bnp in americas cohort. Finehearts-HF ? Next pillar in HFpEF ? #mdt25 #freedomfromfailure @BSHeartFailure
@BeckyHyland3 HFpEF many services do not review this cohort and those that do are often understaffed to manage this complex condition #MDT25 #freedomfromfailure
Obesity and HF . Vicky Ruzalla giving a very informative talk. GLP-1a science goes back 1906 first inj 2005! More than weight loss ⬇️ inflammation, fibrosis , lipids, Visceral fat , BP ⬆️ exercise tolerance , QOL . But should people stay on for life ? #freedomfromfailure #mdt25
